Bone Pain, Breast Cancer Surgery, and a New Face at the Top
Quick Summary
This Friday episode covers three things worth knowing heading into the weekend: a leadership change at The Menopause Society, an evolving conversation about breast cancer surgery, and a new randomized trial testing electrical acupuncture for bone pain after menopause. Light, useful, and worth your commute home.
Bone Pain, Breast Cancer Surgery, and a New Face at the Top
Key Takeaways
- ✦Makeba Williams, MD, FACOG, MSCP is the new president of The Menopause Society — the organization that sets clinical guidance on menopause care in North America.
- ✦A 2026 paper argues that some women with early-stage breast cancer may be able to skip sentinel lymph node surgery — a development with real implications for treatment decisions.
- ✦A new randomized, sham-controlled trial is testing whether electrical pulses applied to acupuncture points can reduce bone pain in postmenopausal women — the sham control group is what makes this design worth watching.
- ✦Sham-controlled trials in acupuncture research are genuinely hard to design, so when a team builds one in, it signals they're trying to separate real effect from placebo — results still pending.
- ✦The Menopause Society's clinical guidance shapes what your doctor knows and recommends — which makes leadership transitions there more relevant to your care than you might think.
Sources & References
Episode Script
Thanks Toni. We've got a good one to close out the week — nothing too heavy, but all three of these are genuinely worth knowing about.
Let's start with some news from The Menopause Society, because I think this organization matters more to your day-to-day care than most people realize, and a leadership change just happened.
Makeba Williams, MD is the new president — her full credentials are FACOG and MSCP, which means she's a board-certified OB-GYN and a certified menopause practitioner. She takes the helm for the 2026-2027 term. The announcement was published in the society's journal this week.
You might be wondering why I'm spending time on an organizational announcement. Fair question. The Menopause Society — it was called NAMS, the North American Menopause Society, until a few years ago — is the group that writes the clinical guidelines your doctor is most likely to have on her desk, or on her screen, when she's figuring out how to handle your care. When they update their position on hormone therapy, or weight-change recommendations, or brain health, that filters down to actual appointments. So who leads that organization, and what they prioritize, is not just inside baseball.
Dr. Williams is an OB-GYN and menopause specialist, and her election to the top seat is worth noting at a moment when menopause care is finally getting some overdue attention — both in research funding and in public conversation. I'll keep an eye on what she emphasizes during her term. That feels like a story worth following.
Breast cancer comes up a lot in the menopause space — partly because breast cancer treatment can itself trigger menopause, sometimes suddenly and harshly, and partly because fear of breast cancer is one of the main reasons women and their doctors are still cautious about hormone therapy. So when the surgical side of breast cancer care shifts, it's relevant here too.
A paper published this week in a surgical journal makes the case that some women with early-stage breast cancer may be able to skip a procedure called sentinel lymph node surgery. I want to explain what that is, because it matters.
When breast cancer is diagnosed, surgeons typically want to know whether the cancer has started spreading to the lymph nodes — the small glands under your arm that are part of your immune system. The standard way to check is to remove one or more of those nodes — the "sentinel" nodes, meaning the first ones the cancer would likely reach — and test them. It's a procedure done under general anesthesia, and it comes with side effects. The main one is lymphedema, which is swelling in the arm that can become a long-term problem. It's not guaranteed, but it's a real risk.
What the author of this paper argues is that for certain women with early-stage breast cancer, the surgical information gained from removing those nodes may not actually change the treatment plan — meaning the surgery carries risk without changing the outcome. The argument is essentially: if you're going to recommend the same treatment regardless of what those nodes show, why put someone through surgery to look?
Now — I want to be careful here, because this is a commentary paper, not a randomized trial. It's one surgeon's argument, well-reasoned and published in a peer-reviewed journal, but it's not settled guidance. The decisions involved are complex, they depend on the specific tumor, the specific patient, and what her oncology team recommends. This is not "skip the surgery" advice from me — that's not my place, and even if it were, that's a conversation for your surgical team.
What I think is worth taking from this: breast cancer surgery is not a fixed protocol. It has evolved and continues to evolve as the evidence changes. If you or someone you love is navigating an early breast cancer diagnosis, it's worth asking your team what the current thinking is on lymph node surgery for your specific situation, and whether there are clinical criteria that would change the recommendation. Surgeons who are up on the literature are having that conversation. You can ask to be part of it.
The third item this week is the one I teased at the top, and I find the design of this study more interesting than the topic might initially sound.
Researchers in China published a protocol — meaning the full plan for a study they're about to run — testing a technique called transcutaneous electrical acupoint stimulation for bone pain in postmenopausal women. That phrase is a mouthful, so let me break it down.
"Transcutaneous" means through the skin. "Acupoint" refers to the specific points used in acupuncture. So this is essentially acupuncture, but instead of needles, you're applying gentle electrical pulses through pads placed on those same points on the skin. It's sometimes called electroacupuncture without the needles.
The pain they're targeting is the kind that comes with osteoporosis — the bone thinning that accelerates after estrogen drops. When bones lose density, they can ache. Vertebrae in particular can cause real chronic pain. It's not just a fracture risk; it's a daily quality-of-life issue, and the options that exist — bisphosphonates, for example — aren't always enough for pain, and they carry their own considerations.
Here's the part I actually want to flag: this trial has a sham control group. That is genuinely harder to design than it sounds when you're studying acupuncture, because how do you fake an acupuncture treatment convincingly enough that participants don't know which group they're in? Some researchers use blunt-tipped placebo needles that press on the skin without penetrating. This study is using sham electrical stimulation — same setup, same equipment, but no actual electrical current delivered to the acupoints. Participants in both groups feel like they're receiving treatment.
That design choice matters a lot. A huge chunk of acupuncture research doesn't bother with a credible sham condition, which makes it nearly impossible to separate the treatment effect from the placebo effect — and placebo is genuinely powerful for pain. When a team goes to the trouble of building a rigorous sham condition, it tells you they're trying to find out if the technique works, not just confirm that it does.
We don't have results yet — this is a protocol paper, so they're publishing their plan before they run the trial. That's actually good scientific practice. It means they're committing to their methods upfront so they can't quietly change them later if they don't like the results. Watch for the follow-up.
For right now: if you're dealing with bone pain — aching back, general joint pain that you know is connected to the osteoporosis conversation your doctor has started — this is a space that's being taken seriously in research. Electrical acupoint stimulation isn't ready to be a recommendation yet, but it's being studied properly, and that's how things actually make it into evidence-based care.
Thanks for spending the week with us. If Hot Flasher is part of your routine, hit subscribe wherever you listen — it's the easiest way to make sure Monday's episode shows up without you hunting for it. Have a good weekend, and I'll see you Monday.
Sources curated automatically by the Hot Flasher pipeline.
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.